tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market
KPTI
Karyopharm Therapeutics
RESEARCH TOOLSreports
Want to see KPTI full AI Analyst Report?

Karyopharm Therapeutics (KPTI) Financial Statements

1,229 Followers

Karyopharm Therapeutics Financial Overview

Karyopharm Therapeutics's market cap is currently $187.33M. The company's EPS TTM is $; its P/E ratio is -0.41; Karyopharm Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 146.07M$ 145.24M$ 146.03M$ 157.07M$ 209.82M
Gross Profit$ 140.12M$ 139.23M$ 141.09M$ 151.86M$ 206.42M
Operating Income$ -90.71M$ -119.44M$ -129.54M$ -142.20M$ -98.27M
EBITDA$ -90.41M$ -38.60M$ -118.42M$ -139.31M$ -96.98M
Net Income$ -196.04M$ -76.42M$ -143.10M$ -165.29M$ -124.09M
Balance Sheet
Cash & Short-Term Investments$ 63.74M$ 108.71M$ 191.44M$ 277.97M$ 228.62M
Total Assets$ 108.42M$ 164.42M$ 240.44M$ 358.17M$ 305.31M
Total Debt$ 233.61M$ 194.52M$ 177.02M$ 179.07M$ 180.58M
Net Debt$ 173.07M$ 132.05M$ 124.78M$ 43.89M$ -9.88M
Total Liabilities$ 401.34M$ 350.44M$ 376.64M$ 374.83M$ 384.98M
Stockholders' Equity$ -292.93M$ -186.02M$ -136.21M$ -16.66M$ -79.67M
Cash Flow
Free Cash Flow$ -75.37M$ -127.63M$ -92.72M$ -149.67M$ -112.83M
Operating Cash Flow$ -75.37M$ -127.49M$ -92.72M$ -149.55M$ -107.12M
Investing Cash Flow$ 43.38M$ 95.47M$ 7.94M$ -104.26M$ 141.84M
Financing Cash Flow$ 30.05M$ 41.65M$ 1.12M$ 193.74M$ 73.65M
Currency in USD

Karyopharm Therapeutics Earnings and Revenue History

Income Statement >

Karyopharm Therapeutics Debt to Assets

Balance Sheet >

Karyopharm Therapeutics Cash Flow

Cash Flow >

Karyopharm Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >